InsidersTradesSigma
Cantargia AB Stock: price and insider trades · Finland · FIN-FSA
Track the Cantargia AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Cantargia AB has published 25 insider filings. Market capitalisation: €543.5m. The latest transaction was disclosed on 29 June 2026 (Purchase). Among the most active insiders: David Liberg. All data is accessible without an account.
25
Insider Decl.
0
Thresholds
€82,184
19 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cantargia AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 10.00.
34Σ signal
Fundamental score
Ranked 4 of 25,921 companies
97.5
score / 100
Value97
Quality98
FCF yld29%
Earn yld29%
EV/EBITDA3.3x
ROE106%
Gross mgn·
Net mgn46%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 June 2026
Declarations25 total
14,012 shares@ SEK 2.250.0005% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-72bb636d19a2ab4034f4
Ideal exit: 23 Mar 2027 (T+270)
63,054 shares0Teckningsrätt/UniträttFI:csv-4daeba8f8c7e6a7ead38
4,444 shares@ SEK 2.250.0002% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-4e872d308724c063e973
Ideal exit: 22 Mar 2027 (T+270)
82,071 shares0Teckningsrätt/UniträttFI:csv-27550c86b989afa7bef3
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
18,238 shares@ SEK 2.250.0007% mcap43.0% of flowBTA (betald tecknad aktie)FI:csv-f97fa789846a229700c1
Ideal exit: 19 Mar 2027 (T+270)
24,986 shares@ SEK 2.250.0009% mcap51.1% of flowBTA (betald tecknad aktie)FI:csv-f5436d02cf084c340bf7
Ideal exit: 19 Mar 2027 (T+270)
33,400 shares@ SEK 2.250.0013% mcap51.1% of flowBTA (betald tecknad aktie)FI:csv-f29e73c163d13a287de2
Ideal exit: 19 Mar 2027 (T+270)
99,999 shares0Teckningsrätt/UniträttFI:csv-fefe5f54db24ca11980a
22,222 shares@ SEK 2.250.0008% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-30ded05acc959807358c
Ideal exit: 20 Mar 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
16,154 shares@ SEK 2.250.0006% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-91a701ea60e3a6b07b24
Ideal exit: 20 Mar 2027 (T+270)
72,693 shares0Teckningsrätt/UniträttFI:csv-e37572574e380fc12427
33,400 shares@ SEK 2.150.0012% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-950ff7d9da4992c21ba2
Ideal exit: 19 Mar 2027 (T+270)
24,986 shares@ SEK 2.150.0009% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-f56980b571841841577c
Ideal exit: 19 Mar 2027 (T+270)
16,666 shares@ SEK 2.250.0006% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-398a39a1d4a2b8ef5a98
Ideal exit: 19 Mar 2027 (T+270)
74,997 shares0Teckningsrätt/UniträttFI:csv-96a3874503e7fd35c431
35,866 shares@ SEK 2.250.0014% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-5a27b362748b543847ec
Ideal exit: 19 Mar 2027 (T+270)
161,397 shares0Teckningsrätt/UniträttFI:csv-ce4bdff3759c92b113c3
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
13,000 shares@ €0.37890.0006% mcap100.0% of flowAktieFI:A003X340-1
Ideal exit: 21 Dec 2026 (T+270)
1,000,000 shares0OptionFI:A003R943-1
Ideal exit: 26 May 2026 (T+270)
250,000 shares0OptionFI:A003R861-1
Ideal exit: 26 May 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
250,000 shares0OptionFI:A003R856-1
Ideal exit: 26 May 2026 (T+270)
250,000 shares0OptionFI:A003R851-1
Ideal exit: 26 May 2026 (T+270)
1,471 shares@ €6.68100.0% of flowAktieFI:A001P629-4
Ideal exit: 16 Oct 2021 (T+270)
1,000 shares@ SEK 62.20100.0% of flowAktieFI:A001P585-1
Ideal exit: 15 Oct 2021 (T+270)
2,000 shares@ SEK 61.50100.0% of flowAktieFI:A001P582-1
Ideal exit: 15 Oct 2021 (T+270)
25 of 25 declarations
About Cantargia AB
Cantargia AB is a Swedish biopharmaceutical company focused on developing treatments for cancer and inflammatory diseases. It is listed on the Stockholm Stock Exchange (XSTO).